Arvee Laboratories (India) Ltd
ARVEE
Company Profile
Business description
Arvee Laboratories (India) Ltd is a specialty chemical company. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
Contact
Iskcon Bopal Road
403, Entice Building
Opposite Jayantilal Park BRTS Bus Stop
Ambli
AhmedabadGJ380058
INDT: +91 2717430479
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 March 2026
Employees
65
Stocks News & Analysis
stocks
3 global ‘buy the dip’ candidates with wide moats
Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.
stocks
What next for Nine Entertainment after Domain payout?
The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,135.20 | 24.60 | 0.27% |
| CAC 40 | 7,823.52 | 62.20 | 0.80% |
| DAX 40 | 23,703.65 | 70.70 | 0.30% |
| Dow JONES (US) | 46,108.00 | 617.08 | 1.36% |
| FTSE 100 | 9,297.58 | 72.19 | 0.78% |
| HKSE | 26,371.49 | 285.17 | 1.09% |
| NASDAQ | 22,043.07 | 157.01 | 0.72% |
| Nikkei 225 | 44,694.65 | 322.15 | 0.73% |
| NZX 50 Index | 13,237.56 | 8.41 | 0.06% |
| S&P 500 | 6,587.47 | 55.43 | 0.85% |
| S&P/ASX 200 | 8,870.00 | 27.10 | 0.31% |
| SSE Composite Index | 3,870.50 | 4.80 | -0.12% |